HomeXLO • NASDAQ
add
Xilio Therapeutics Inc
Nakaraang pagsara
$8.48
Sakop ng araw
$8.20 - $8.57
Sakop ng taon
$6.47 - $16.52
Market cap
49.21M USD
Average na Volume
42.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.69M | 693.85% |
Gastos sa pagpapatakbo | 63.44M | 32.92% |
Net na kita | 10.36M | 179.13% |
Net profit margin | 75.70 | 109.97% |
Kita sa bawat share | — | — |
EBITDA | -11.51M | 13.13% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 137.53M | 148.74% |
Kabuuang asset | 154.68M | 117.64% |
Kabuuang sagutin | 119.41M | 123.30% |
Kabuuang equity | 35.27M | — |
Natitirang share | 5.78M | — |
Presyo para makapag-book | 1.09 | — |
Return on assets | -20.52% | — |
Return on capital | -142.96% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 10.36M | 179.13% |
Cash mula sa mga operasyon | -2.00M | 85.89% |
Cash mula sa pag-invest | -95.00K | -1,483.33% |
Cash mula sa financing | 35.87M | 337.28% |
Net change in cash | 33.77M | 666.57% |
Malayang cash flow | 6.86M | 131.98% |
Tungkol
Itinatag
2016
Headquarters
Website
Mga Empleyado
76
